Skip to main content
Briefings in Functional Genomics logoLink to Briefings in Functional Genomics
. 2021 Jun 25;21(2):78–89. doi: 10.1093/bfgp/elab028

Bioinformatics tools used for whole-genome sequencing analysis of Neisseria gonorrhoeae: a literature review

Reema Singh 1, Anthony Kusalik 2, Jo-Anne R Dillon 3,
PMCID: PMC9001900  PMID: 34170311

Abstract

Whole-genome sequencing (WGS) data are well established for the investigation of gonococcal transmission, antimicrobial resistance prediction, population structure determination and population dynamics. A variety of bioinformatics tools, repositories, services and platforms have been applied to manage and analyze Neisseria gonorrhoeae WGS datasets. This review provides an overview of the various bioinformatics approaches and resources used in 105 published studies (as of 30 April 2021). The challenges in the analysis of N. gonorrhoeae WGS datasets, as well as future bioinformatics requirements, are also discussed.

Keywords: bioinformatics, Neisseria gonorrhoeae, whole genome sequencing, antimicrobial resistance, molecular epidemiology, strain typing, population structure

Introduction

Gonorrhoea, caused by the Gram-negative bacterium Neisseria gonorrhoeae (gonococcus), is the second most common sexually transmitted infection worldwide with a prevalence estimated at 86 million cases [1, 2]. Untreated infections in females, who bear the burden of this disease, and who are often asymptomatic, can lead to severe health outcomes such as pelvic inflammatory disease, ectopic pregnancy, infertility and occasionally maternal death [2]. Infections may be transmitted to children during childbirth; neonatal ophthalmia was a leading cause of blindness prior to antibiotic prophylaxis. Males, who are usually symptomatic, can also suffer complications such as epididymitis and infertility. Both sexes may experience complications such as arthritis, blood stream and joint infections. The progressive development of antimicrobial resistance (AMR) in N. gonorrhoeae isolates to all classes of antibiotics [i.e. sulphonamides, penicillins, tetracyclines, macrolides (e.g. azithromycin), fluoroquinolones, and even the last recommended monotherapeutic antibiotic class, third-generation cephalosporins], has compounded difficulties in treating gonorrhoea infections and may produce untreatable infections in the future [3, 4]. Because of AMR, N. gonorrhoeae has been placed on the antibiotic watch lists of the World Health Organization and many countries worldwide [2–5].

Whole-genome sequencing (WGS) of N. gonorrhoeae isolates has been widely used to predict AMR, to identify novel mutations and mechanisms associated with gonococcal AMR, to ascertain strain types (STs), for molecular epidemiological surveillance (micro and macro epidemiological analysis), to track gonococcal transmission and for phylogenetic analysis [3, 6–9]. Only one report reviewed the bioinformatics resources that have been used for the analysis of N. gonorrhoeae genome sequencing datasets [10]. The present article provides an overview of widely used, as well as specifically designed bioinformatics tools for the analysis of N. gonorrhoeae) whole genomes; 105 published studies (last literature search 30 April 2021) were reviewed. The majority of the studies used the Illumina sequencing platform, but the few which used Nanopore or PacBio are also referenced. This review provides insights into the varieties of analyses (e.g. AMR analysis and prediction, molecular epidemiology, strain transmission, strain typing, population structure analysis) used by investigators for analyzing gonococcal genomes. Also, this review is intended especially for those with moderate to no bioinformatics backgrounds who would like to analyze genomic sequences for N. gonorrhoeae. Current challenges, possible solutions and future directions for N. gonorrhoeae WGS data analysis are discussed.

Bioinformatics tools for the analysis of Neisseria gonorrhoea WGS data

Several steps can be included in the analysis of WGS datasets. Some are essential and others can be optional (Supplementary Table 1). These steps may include: (i) data cleaning, (ii) de novo assembly, (iii) scaffolding, (iv) quality assessment of assembled genomes and annotation, (v) read mapping, variant calling and core genome analysis, (vi) strain typing and AMR prediction, and (vii) phylogenetic analysis and visualization of trees.

Data cleaning (i.e. quality check, trimming and contamination check)

The quality (e.g. per-base sequence quality, adapter content, and sequence duplication level) of the DNA analyzed should be ascertained. Generally, WGS datasets are submitted in the FASTQ (or FASTA) [11] format, and quality is generally ascertained using FastQC [12], fastp [13], NGSQC toolkit [14] or PRINSEQ-lite [15] programs. Thirty-six (of 105) published gonococcal WGS studies [16–51] reported assessing the quality of N. gonorrhoeae raw reads before performing downstream analyses; 20 used FastQC [18–23, 28, 32–36, 40, 41, 43, 46, 48–51]; 2 each used fastp [42, 47] or PRINSEQ-lite [27, 30] and 1 used NGSQC toolkit [24]. Ten studies [16, 17, 26, 29, 31, 37–39, 44, 45] used pipelines that incorporate some of the above programs (i.e. Nullarbor [52], Gen2Epi [48], Explify [https://www.idbydna.com/explify-platform/], Shovill [https://github.com/tseemann/shovill] and INNUca [53]).

WGS reads of poor quality (adapter sequences not removed and low-quality bases) could lead to longer computational times and possibly inaccurate results (e.g. Single Nucleotide Polymorphisms (SNPs) analysis) [54]. Trimming (eliminating poor quality regions) may be performed using programs such as Trimmomatic [55], Cutadapt [56], PRINSEQ-lite [15], FASTX (http://hannonlab.cshl.edu/fastx_toolkit/index.html), Sickle (https://github.com/najoshi/sickle), ConDeTri [57], SolexaQA [58], ERNE-FILTER [54], Trim Galore [59], Nesoni (https://pypi.org/project/nesoni/) and fastp [13]. Thirty-nine of 105 published N. gonorrhoeae WGS studies [16, 17, 21–24, 26–39, 41, 42, 44–46, 48, 49, 51, 60–70] performed trimming; 13 used Trimmomatic [23, 32, 34, 36, 48, 51, 60–62, 66, 67, 69, 70]; 5 used Cutadapt [21, 35, 41, 44, 46]; two each used fastp [42, 63], Trim Galore [33, 64] or PRINSEQ-lite [27, 30]; and 1 each used Nesoni [22], Sickle [28] or NGSQC toolkit [24]. Eleven reports [16, 17, 26, 29, 31, 37–39, 45, 65, 68] used pipelines with in-built functions for trimming (i.e. Gen2Epi, CLC Genomics Workbench [https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-clc-genomics-workbench], INNUca, Shovill, Exemplify, JEKESA and Nullarbor). Sixty-six (of 105) studies did not report trimming, possibly because the raw reads were of good quality. Nevertheless, ideally quality check reports should be included in Supplementary data.

Contamination removal (i.e. identifying reads present from species other than N. gonorrhoeae) is generally accomplished using programs such as Kraken [71], DeconSeq [72], MetaPhlAn2 [73], KmerFinder [74, 75] and ConFindr [76] (Supplementary Table 2). These programs are k-mer (a subsequence of length k) based taxonomic identification tools. Eighteen of 105 published gonococcal WGS studies in which DNA was extracted from pure cultures [16, 17, 21, 26, 31, 32, 36, 37, 41, 42, 46, 48, 51, 60, 62, 77–79] performed a contamination check; 10 applied Kraken [21, 32, 41, 42, 46, 48, 51, 62, 78–79] and 3 used either DeconSeq [60] or MetaPhlAn2/ MetaPhlAn [40]. Five studies used pipelines (i.e. Nullarbor, Gen2Epi), which include Kraken [16, 17, 26, 31, 37] for contamination checks. The contamination removal step may not be required when gonococcal DNA is extracted from pure cultures or when the majority (~90% if possible) of the WGS reads are N. gonorrhoeae. Ideally, authors should include data cleaning reports as supplementary data.

Data cleaning is especially relevant when analyzing gonococcal genomes directly purified from clinical specimens (e.g. urinary, vaginal, cervical and body fluids). Different species may occur in unknown abundance, mainly in low quantity, which could make the identification of gonococcal reads in such specimens problematic. Further, the presence of multiple gonococcal strains or closely related species could lead to genome assemblies containing chimeric contigs. Hardick et al. [80] performed N. gonorrhoeae WGS from clinical swabs (oral, rectal and urinary) and found that aside from a low concentration (0.001–0.178%) of gonococcal DNA in some clinical samples, mixed bacterial species in rectal and urinary swabs complicated the bioinformatics analyses steps; they used KmerFinder to remove contaminations. In another study, Graham et al. [81] removed human sequences from urine specimens using Kraken before generating the de novo assembly of N. gonorrhoeae short reads.

De novo assembly

De novo assembly is the process of constructing longer continuous stretches, called contigs, from clean reads without prior knowledge of the genome sequence. Commonly used software for de novo assembly are SPAdes [82], Velvet [83], Abyss [84], Unicycler [85], CLC Genomics workbench, Nullarbor, Gen2Epi, INNuca, Shovill, JEKESA (https://github.com/stanikae/jekesa), GS de novo assembler, IDBA-UD [86], Newbler (https://cals.arizona.edu/swes/maier_lab/kartchner/documentation/index.php/home/docs/newbler), Sanger Institute Assembly pipeline [87] or A5-Miseq (https://github.com/koadman/docker-A5-miseq) (Supplementary Table 2).

SPAdes [82], uses a De Bruijn graph algorithm to assemble short reads into contigs. Forty-four (of 105) published N. gonorrhoeae WGS studies (Supplementary Table 1) [18–23, 32–36, 40–43, 46, 48, 49, 51, 60–63, 66, 69, 78, 88–105] generated de novo contigs using SPAdes. Other studies (n = 45) used programs such as Velvet (n = 9) [27, 106–113], CLC Genomics workbench (n = 11) [65, 77, 114–122]. Seven used Unicycler [47, 64, 67, 70, 123–125]; four used the Nullarbor pipeline [16, 26, 31, 37]; three used the Sanger Institute Assembly pipeline [25, 79, 126]; two each used INNuca [29, 45] and Abyss [28, 127]; and one each used Shovill [38], the Gen2Epi pipeline [17], JEKESA [68], GS de novo assembler [128], IDBA-UD [30], Newbler [129] and A5-Miseq [130]. Sixteen (of 105) studies [24, 39, 44, 79, 131–142] did not use this step, as the WGS were was only used for either variant calling or multivariant linear regression analysis. De novo assembly should be performed for questions such as identifying variants or complex rearrangements in the genome, preforming genome comparisons, and AMR prediction.

Scaffolding

De novo contigs of N. gonorrhoeae can be assembled into longer sequences called scaffolds. Scaffolding is optional; most studies have no requirement for this step. Scaffolding is usually performed to refine assembled genomes because draft assemblies may contain genes split over several contigs [125]. For example, Brynildsrud et al. [125] found that in some N. gonorrhoeae WGS assemblies, the modB gene was split over several contigs [125]. In another study, Suwayyid et al. [143] reported that the Nf1 gene was split across two contigs. The main reason for such fragmentation is the high number of repetitive sequences in N. gonorrhoeae [144].

Different algorithms and technologies used for scaffolding were reviewed by Ghurye and Pop [145]. Only a few pipelines for N. gonorrhoeae include scaffolding features (i.e. Sanger Institute Assembly pipeline [87] and Gen2Epi [48]). Parmar et al. [17, 146] applied Gen2Epi [48] to assemble N. gonorrhoeae de novo contigs into scaffolds. Harris et al. [25], Town et al. [79] and Sánchez-Busó et al. [126] used the Sanger Institute Assembly pipeline [87] to generate and improve gonococcal genome assemblies (Supplementary Table 2).

Scaffolding may introduce assembly problems such as missing information caused by the presence of long sequences of ambiguous nucleotides, as observed in analyses performed using Gen2Epi [17, 48, 51]. For gonococcal WGS analysis, methods to assemble contigs into longer, relatively error-free scaffolds should be developed to provide longer genomes. Alternatives for obtaining longer reads include using sequencing methods such PacBio or Oxford Nanopore [47, 50, 67, 103, 147].

Quality assessment of assembled genomes and annotation

After the assembly/scaffolding steps, genomes may be assessed for quality using the program Quality Assessment Tool for Genome Assemblies (QUAST) [148]. QUAST [148], (https://github.com/ablab/quast), compares and evaluates genome assemblies on the basis of ‘N’ statistics (N50, NA50, NGA50) values, the total number of contigs and misassemblies. This important step is performed to check the completeness and accuracy of the assembled genomes. Twenty N. gonorrhoeae WGS studies used QUAST to evaluate the quality of assembled genomes [21, 30, 32–34, 36, 38, 42, 47, 48, 51, 60, 69, 88, 95–98, 100, 104]. Pipelines used to assess the quality of assembled genomes included Nullarbor (n = 4) [16, 26, 31, 37], INNUca (n = 2) [29, 45], Gen2Epi (n = 1) [17] and JEKESA (n = 1) [68]. Preferably, data on quality assessment could be included in Supplementary materials when submitting peer-reviewed articles.

Annotation of assembled genomes is used to identify key features (e.g. various genes with known and unknown functions and their products, mobile genetic elements, genome duplications). Frequently used programs for annotation are Prokka [149], Prodigal [150], and the pipelines NCBI prokaryotic genome annotation [151] and DFAST [152] (Supplementary Table 2). Prokka was used to annotate N. gonorrhoeae assemblies in 25 studies [16, 18, 19, 22, 23, 26, 30, 31, 34, 37, 38, 40, 44, 49, 50, 60, 62, 69, 78, 89, 90, 101, 103, 111, 130]; 4 used the NCBI prokaryotic genome annotation pipeline [27, 33, 47, 68]; 3 used Prodigal [17, 48, 51] and 1 used DFAST [64]. Although this step is optional, annotation results, such as total number of predicted genes and their positions, could be helpful to assess the completeness of the assembled genome and could be included in Supplementary data of papers.

Read mapping, variant calling and core genome analysis

In the read mapping step, short WGS reads are aligned against (an) N. gonorrhoeae reference genome(s) using programs such as Burrows–Wheeler Alignment (BWA) [153], Bowtie [154], Stampy [155], ParSNP [156], Galaxy SNVPhyl Workflow [157], Gen2Epi [48], CLC Genomics workbench, Snippy [158] and SMALT [159] (Supplementary Table 2). This step is important if the objective is to perform SNP analysis (for core genome and AMR prediction) and to find the total number of N. gonorrhoeae reads in WGS samples. Thirty-one studies (of 105) used BWA [16, 24, 30, 31, 37, 38, 40, 42, 44, 49, 50, 62, 78, 79, 91, 93, 94, 100, 104, 105, 107, 110, 113, 117–119, 123, 124, 132, 133, 138]; 10 used SMALT [18–20, 106, 114, 77, 121, 129, 126, 131]; 3 each used ParSNP [101, 102, 160] or Stampy [108, 109, 136]; 2 each used Galaxy SNVPhyl Workflow [89, 90], CLC Genomics workbench [112, 122], Snippy [26, 92] and Bowtie [48, 51]; and one used Gen2Epi [17].

The variant calling step is required if the objective of a study is to perform evolutionary analyses (e.g. to study gonococcal AMR and/or gonorrhea transmission). Frequently used programs for variant calling are: SAMtools [161], GATK [162], Pilon [163], Snippy [158], Pathogenwatch [36], SNVPhyl [157], CLC Genomics workbench, SSAHA pipeline [164] or Freebayes [165] (Supplementary Table 2). SAMtools [161], used for post-processing (such as indexing, sorting, data extraction and format conversion) of alignment files (output files generated after aligning short reads to the reference genomes), has been used for variant calling [20, 30, 42, 44, 77–79, 109, 113, 114, 116, 117, 121, 123, 124, 126, 131, 132, 136], SNP verification by comparing reads or assemblies to the reference genome [94], per-base position information determination [91], sorting and indexing the alignment file [20], format conversion of the alignment file [79] and determining base count and nucleotide ratio [112, 113]. Twenty-one reports used Samtools [20, 24, 30, 42, 44, 77–79, 108, 109, 113, 114, 116, 117, 121, 123, 124, 126, 131, 132, 136]; six used ParSNP [41, 46, 61, 101, 102, 112]; four each used Freebayes [18, 19, 37, 62] or GATK [91, 94, 134, 142]; two each used Pilon [40, 100] or SNVPhyl [89, 90]; and one each used Snippy [92], Pathogenwatch [36], CLC Genomics workbench [122] and the SSAHA pipeline [129]. Sixty-two studies did not require this step for analysis (Supplementary Table 1).

Core, pan- and accessory genomic analysis of assembled genomes is optional and is performed using Roary [166] and ParSNP [156]. Eight of 33 N. gonorrhoeae WGS studies in which core genomes were analyzed performed phylogenetic analysis using Roary [25, 49, 50, 60, 78, 103, 111, 126], and 8 used ParSNP [21, 22, 32, 35, 63, 95, 99, 125]. Three studies [32, 35, 99] did not describe whether WGS reads or assembled contigs were used to generate core genome alignments; this information is critical to ascertain whether alignments were based on whole or core genomes.

Strain Typing and AMR prediction

Various schemes have been used to type N. gonorrhoeae isolates using molecular methods [i.e. N. gonorrhoeae multi-antigen sequence typing (NG-MAST), multi-locus sequence typing (MLST) and N. gonorrhoeae sequence typing for AMR (NG-STAR)] [167–169] for purposes such as ascertaining gonococcal population structure, strain transmission and AMR identification [16–37, 60–65, 77–79, 88–100, 106, 108–112, 114, 116–121, 123, 124, 126–132, 134–138]. NG-MAST [168], an online database available at http://www.ng-mast.net, includes sequence data for two highly polymorphic antigen-encoding loci, porB (porin B) and tbpB (transferrin-binding protein B). The sequences of both loci are assigned individual allele numbers, and a distinctive ST is assigned to each allelic profile. This typing scheme has also been implemented in various programs such as NGMASTER [170], short read sequence typing (SRST) [171], Gen2Epi [48], Gen2EpiGUI [51] and pubMLST [167] to assign NG-MAST STs to the assembled queries (Supplementary Table 2).

For MLST typing, the Bacterial Isolate Genome Sequence Database (BIGSdb), a widely used database hosted by pubMLST.org [167, 172, 173], contains 9206 N. gonorrhoeae of 618 426 genomes (as of 20 May 2021). The BIGSdb platform exploits stored sequence data (submitted via the pubMLST submission system) of gonococcal specimens ranging from short Sanger sequencing reads to whole genomes (assembled contigs or complete genomes). The pubMLST platform also hosts several web-based and stand-alone tools to identify MLST sequence types (i.e. alleles of abcZ, adk, aroE, fumC, gdh, pdhC and pgm) directly from sequence reads. Information present in the pubMLST typing databases is also used in other programs, such as antimicrobial resistance identification by assembly (ARIBA) [174], SRST [171], Gen2Epi [48] Gen2EpiGUI [51] and MLST [175], to assign MLST STs.

Several general databases, such as Comprehensive Antibiotic Resistance Database (CARD), Pathosystems Resource Integration Center (PATRIC) and Lactamase Engineering Database (LacED) [176, 177, 178] catalogue antibiotic resistance determinants [179, 180]. A variety of tools have also been used to predict AMR profiles in bacteria, including N. gonorrhoeae [129, 176] e.g. Resistance Gene Identifier (RGI), Basic Local Alignment Search Tools (BLAST), Rapid Annotation Using Subsystems Technology (RAST) [180], Antibiotic Resistance Gene-ANNOTation (ARG-ANNOT) [179], ResFinder [181], ARIBA [174], ABRicate [182], ResFinder, PointFinder and NG-STAR [183–187].

CARD [176] was developed to store sequences of genes carrying resistance to various antibiotics along with relevant metadata. Other tools available in CARD for quick identification and visualization of antibiotic resistance genes in new, unannotated genomes [23], include RGI and BLAST. A recent release (3.0.3) of CARD included N. gonorrhoeae AMR information collected from systematic reviews [176]. Kubanov et al. [23] used the RGI web portal from CARD to search for and analyze AMR genetic determinants in genomic sequences of N. gonorrhoeae strains.

PATRIC [177] is an online resource created to store and integrate different types of data such as genomic, transcriptomic, protein–protein interaction, three-dimensional structure, taxonomic, and typing data. Currently, PATRIC contains 419 985 bacterial genomes including 7741 genomes (as of 20 May 2021) of N. gonorrhoeae. PATRIC uses RAST [180] for the annotation of genomes. Kivata et al. [183] identified the determinants of fluoroquinolone resistance in N. gonorrhoeae whole genomes with RAST implemented in PATRIC. Other studies used the independently hosted RAST server (https://rast.nmpdr.org/) to annotate N. gonorrhoeae genomes for AMR [129, 183–185]; Ang et al. [184] reported determinants associated with resistance to ciprofloxacin, penicillin and tetracycline in a strain of N. gonorrhoeae. Marri et al. [185] and Didelot et al. [129] utilized RAST for annotation, without AMR prediction. The program ARG-ANNOT [179] was used by Ryan et al. [92] to detect AMR determinants in 609 genomes of N. gonorrhoeae isolates.

ARIBA (https://github.com/sanger-pathogens/ariba) identifies AMR associated variants and genes directly from short sequencing reads [174]. Ten studies used ARIBA to analyze N. gonorrhoeae AMR [22, 29, 42, 45, 62, 63, 126, 130, 140, 188]. For example, Town et al. [188] identified mutations in gyrA, mtrR, porB1b, ponA, parC, blaTEM and penA alleles implicated in AMR and also used the ARIBA micplot module to associate the Minimum Inhibitory Concentrations (MICs) of 1277 N. gonorrhoeae isolates [188]. Sánchez-Busó et al. [126] detected the presence of blaTEM and tetM in 419 N. gonorrhoeae isolates and Yahara et al. [130] and Williamson et al. [62] identified known AMR genetic markers and variants in 271 and 2186 N. gonorrhoeae genomes, respectively, using ARIBA.

ABRicate [182], an AMR gene detection program used in four published gonococcal WGS studies [16, 26, 31, 37], links assembled genomes to AMR profiles. Other tools, such as ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/) and PointFinder (https://bitbucket.org/genomicepidemiology/pointfinder/src/master/), were used to identify chromosomal mutations and horizontally acquired AMR genes in N. gonorrhoeae [181, 189]. Four studies used ResFinder to investigate AMR genes [60, 81, 95, 109] and Bailey et al. [60] determined AMR-associated genes from N. gonorrhoeae WGS datasets using both ResFinder and PointFinder.

A web-based application specific to N. gonorrhoeae, NG-STAR, (https://ngstar.canada.ca/pages/welcome?lang=en) analyzes the nucleotide sequences of seven genes (penA, mtrR, porB, ponA, gyrA, parC and 23S rRNA) associated with AMR [169]. NG-STAR performs AMR prediction of specific gene sequences and provides allele types and an NG-STAR ST. Forty-three of 105 published gonococcal WGS studies used the NG-STAR scheme for AMR prediction.

AMR prediction tools for N. gonorrhoeae WGS analyses are based on prior knowledge of resistance mutations associated with resistance phenotypes; they do not identify novel mutations conferring AMR, which could be located in intergenic regions or novel genes. Shi et al. [190] proposed a deep learning (DL)-based workflow named Deep Neural Pursuit-Average Activation Potential to identify existing as well as novel point mutations possibly conferring AMR in N. gonorrhoeae using WGS data paired with MICs for five antibiotics. Eyre et al. [113] used multivariate linear regression to predict genetic determinants of MICs for penicillin, tetracycline, azithromycin, cefixime and ciprofloxacin in 681 WGS datasets of N. gonorrhoeae [113]. Alternatively, using seven N. gonorrhoeae WGS datasets (n = 4358) with associated ciprofloxacin and azithromycin MICs, Hicks et al. [104] evaluated the performance of various machine learning (ML) algorithms (e.g. set covering machine, random forest classification and regression) to predict AMR phenotypes from WGS data. To improve ML-based AMR predictions in future, Hicks et al. [104] suggested that more diverse WGS datasets paired with antibiotic susceptibility data be analyzed, a consistent standard protocol to measure the MICs be followed, and more ML algorithm types (e.g. Bayesian framework and neural networks) be implemented and evaluated on larger N. gonorrhoeae WGS datasets. Recently, a Prediction of Antimicrobial Resistance by MAPping (PARMAP; https://github.com/452990729/PARMAP) program was developed to identify AMR in the pan genomes of bacteria [191]. The authors validated this method using 1597 N. gonorrhoeae genomes [160] and identified existing as well as novel mutations associated with ciprofloxacin resistance.

Genome wide association studies (GWAS) is a technique used for the analysis of multiple variants in datasets to test associations between genotype variants and phenotype. Three research articles used GWAS to identify novel AMR determinants in N. gonorrhoeae [49, 105, 160]. Ma et al. performed multiple regression-based GWAS in N. gonorrhoeae isolates (n = 4852) and found variations due to unknown genetic loci in the predicted values of MIC for azithromycin, ciprofloxacin and ceftriaxone, as compared to the original MIC values [49]. Ma et al. [105] also implemented the same approach to identify novel mutations associated with increased azithromycin resistance in N. gonorrhoeae . Using single-site GWAS analysis, Schubert et al. [160] discovered 35 genomic loci and 240 epistatic pairs (i.e. where the effect of a gene mutation depends on the absence or presence of the mutation in other genes) associated with increased resistance to five antibiotics in a dataset of 1102 N. gonorrhoeae isolates.

LacED [178] is an extension of the Jacoby and Bush ß-lactamase list [192] (a curated database of ß-lactamases, which is no longer updated) which allows users to detect TEM (named after the patient, Temoniera, from whom it was isolated) ß-lactamases with novel mutation profiles [186, 187]. This database provides structural, annotation and alignment information related to different TEM ß-lactamases (numbered according to the scheme proposed by Ambler [193]). LacED was used by Muhammad et al. [186] and Stefanelli et al. [187] to compare gonococcal ß-lactamase sequences and assign blaTEM numbering according to the Ambler scheme [186, 187]. Singh et al. [194] characterized a novel ß-lactamase-producing plasmid in N. gonorrhoeae, pJRD20 (Canada type), compared its TEM sequence using the Ambler scheme and identified a unique 6 bp deletion responsible for a unique truncation of TEM.

Phylogenetic analysis and visualization of trees

Because N. gonorrhoeae acquires genetic diversity in its core genome by homologous recombination [195], recombinant fragments must be removed before generating phylogenies; recombined regions within a genome may lead to incorrect phylogenetic trees and inferences. Artifacts that can be introduced include loss of molecular clock, overestimation of the number of mutations and substitution rate heterogenicity, wrong clonal relationships, and star-shaped tree topology with long terminal branches [196]. Genealogies Unbiased By recomBination In Nucleotide Sequences (Gubbins), a tool to identify and remove recombinations from bacterial genomes [197], uses a spatial scanning statistical framework to remove recombined regions by identifying the loci containing elevated base substitution densities. Gubbins is very effective in identifying mosaic recombination and recombined regions presenting mobile genetic elements, and analyzing a large collection of bacterial WGS datasets. Gubbins was used in 37 gonococcal WGS studies [16, 21, 22, 31, 32, 35, 37, 40–42, 46, 49, 61–63, 69, 70, 78, 79, 91–93, 100–102, 105, 107, 114, 116–119, 121, 125, 126, 129, 130] to detect and/or delete recombination events.

ClonalFrame [198, 199], suitable for smaller WGS data sets, establishes the clonal relationship between bacterial isolates by identifying regions with homologous recombination and point mutations. A new implementation of this program, ClonalFrameML, was developed to handle a large WGS datasets. Seven studies used ClonalFrameML [26, 103, 108, 123, 133, 134, 136], two used Galaxy SNVPhyl [89, 90] and one used Harvest Suite (https://github.com/marbl/harvest) [95] to remove recombination.

Phylogenomic trees are generated using Randomized Axelerated Maximum Likelihood (RAxML) [200], PhyML [201], MEGA [202], FastTree [203], IQ-Tree [204], BEAST [205], Phylip [206], Phyloviz [207], Interactive Tree of Life (iTOL) [208], DNAml [201], GrapeTree [209], SplitsTree [210], PathoBacTyper (http://halst.nhri.org.tw/PathoBacTyper/) and RapidNJ [211] (Supplementary Table 2). RAxML[200] uses the maximum likelihood method to build phylogenetic trees from large datasets. Seventy-six of 105 papers performed phylogenetic analyses (Supplementary Table 1). Thirty-two reports utilized RAxML [21–24, 26, 31, 32, 35, 40–42, 46, 60, 61, 69, 77–79, 88, 91, 93, 94, 99, 100, 103, 112, 114, 116–118, 121, 126]; 10 used PhyML [18, 19, 92, 102, 106, 108, 111, 129, 130, 133]; 9 used IQ-Tree [16, 30, 37, 44, 62, 63, 70, 101, 119]; 5 used MEGA [20, 28, 50, 120, 138]; 3 each used ITOL [49, 95, 105], Phylip [27, 134, 142] or Phyloviz [29, 45, 139]; 2 each used BEAST [123, 124] or Galaxy SNVPhyl [89, 90]; and 1 each used DNAml [127], GrapeTree [112], SplitsTree [110], FastTree [43], CLC Genomics workbench [34], PathoBacTyper [17] or RapidNJ [125].

Phylogenetic trees can be visualized using tools such as iTOL [208], Figtree [212], Phyloviz [207], Pathogenwatch [36] and ggtree [213] (Supplementary Table 2). Fifteen studies used iTOL [16, 17, 24, 32, 35, 40, 42, 44, 49, 60, 69, 93, 95, 105, 126]; 8 used Figtree [18, 19, 22, 23, 78, 103, 112, 130], 2 used MEGA [134, 142] and 1 used GrapeTree [125].

BLAST and computational pipelines for analyzing N. gonorrhoeae WGS data

BLAST [214] has been utilized in many analytical tools, pipelines, and databases as outlined previously. However, stand-alone BLAST searches followed by manual examination were used in 34 N. gonorrhoeae WGS studies [18–21, 25, 30, 34, 36, 44–46, 48–50, 61–63, 69, 70, 91, 93, 94, 98, 100, 103, 105, 111, 113, 125–127, 129, 130, 188]. For example, Yahara et al. [130] extracted nucleotide sequences in order to perform in silico MLST typing, penA genotyping, identification of blaTEM and tetM genes, and to search for recombinant fragments within penA. BLAST was used to compare gonococcal genomes [50], for AMR determinant identification [20, 25, 48, 51, 61, 98], for the detection of mobile genetic elements [79, 129] and for in silico NG-MAST genotyping [18, 48, 51, 91, 94].

Several pipelines and platforms combine multiple WGS analysis steps (Gen2Epi, Nullarbor, INNUca, Sanger Sequencing assembly Pipeline and Pathogenwatch). Gen2Epi automatically links genomic scaffolds to AMR and molecular epidemiology data (NG-MLST, NG-MAST and NG-STAR) for N. gonorrhoeae [48]. Gen2Epi is a command-line tool in which WGS analysis of N. gonorrhoeae is completed in 5 simple integrated options (i.e. data cleaning, de novo assembly, scaffolding, assembly quality assessment and annotation, plasmid-type identification, and AMR and epidemiological analysis). A user-friendly interface for Gen2Epi, Gen2EpiGUI, [51] is available at ftp://www.cs.usask.ca/pub/combi [51]. Novel functions to automatically download and update the underlying databases (i.e. NG-MAST [168], NG-MLST [167] and NG-STAR [169]), which are not available in Gen2Epi, have also been implemented in Gen2EpiGUI [51]. The code for Gen2Epi and Gen2EpiGUI is publicly available at https://github.com/DillonLab and https://github.com/ReemaSingh; GitHub, a code-hosting platform for collaboration and version control, allows researchers from around the world to improve these programs.

Nullarbor [52], using a command-line interface, comprises multiple WGS analysis steps including NG-MLST analysis, AMR prediction, and variant calling, although NG-MAST and NG-STAR analysis is not available. Four studies performed various WGS analysis of N. gonorrhoeae using Nullarbor to investigate gonorrhoea transmission, AMR profiles and to perform various assembly and annotation functions [16, 26, 31, 37]. INNUca (https://github.com/B-UMMI/INNUca) provides analysis functions for quality check, contamination detection, de novo assembly, and quality assessment of assembled contigs and has in-built capacity for MLST analysis. Two studies used the INNUca pipeline [29, 45], and three studies used the Sanger Institute Assembly pipeline [25, 79, 126] for WGS data analysis. Pathogenwatch was used for molecular typing, AMR prediction and whole-genome phylogenetic clustering (and visualization) using epidemiological and phenotypic data [25, 36, 61]; its main limitation is that it does not provide resources for functions such as data cleaning, de novo assembly, NG-STAR analysis and annotation.

Conclusions and recommendations

This review is the first report to catalogue the computational tools used for the analysis of N. gonorrhoeae WGS data. A variety of approaches have been taken for various analyses.

For accurate WGS analysis the following approaches should be taken to (i) clean N. gonorrhoeae WGS reads by removing adapters and contaminated sequences from other microorganisms, (ii) identify and remove recombinant regions from the genome before performing phylogenetic analysis, and (iii) analyze all samples using identical commands and parameters during the processing steps. Authors should consider including complete analysis strategies [including software versions, scripts, or workflows, such as provided by Galaxy (https://galaxyproject.org/) and Jupyter notebooks (https://jupyter.org/)] in the methods section of each manuscript.

Many pipelines require advanced bioinformatics skills (e.g. Gen2Epi, the Sanger Institute Assembly pipeline, INNUca and Nullarbor). If pipelines are not accessed for analysis, multiple individual programs must be implemented to achieve steps such as data cleaning, assembly, gene prediction and annotation, strain typing, and AMR prediction. These programs and pipelines often employ a Linux-based command-line interface using different languages such as R, Perl and C++, which can be difficult for those with minimal training in bioinformatics. Analyses of gonococcal genomes using user-friendly tools such as Gen2EpiGUI, Pathogenwatch, pubMLST simplifies bioinformatics analyses for those with more limited bioinformatics skills. Laboratories that conduct analysis of large data sets, requiring repetitive steps (i.e. de novo assembly and strain typing) may benefit from these pipelines and platforms rather than accessing individual programs. On the other hand, the requirement for transmission and evolutionary analyses may require a unique combination of tools for variant calling, recombination removal and phylogenetic analysis tools, such as SAMtools [161], Freebayes [165], Gubbins [197], ClonalFrameML [198, 199], RAxML [200] and PhyML [201]. For example, Koboldt et al. [215] listed best practices for accurate variant calling in clinical samples, such as removing false positives and manually visualizing the alignment in clinical samples.

Currently, there is no single platform that contains all functions required for complete N. gonorrhoeae WGS data analysis. For instance, Gen2Epi can perform data cleaning, de novo assembly, scaffolding and annotation, plasmid assembly, strain typing and AMR prediction, but analysis steps like variant calling, recombination removal and core genome phylogeny are missing. Likewise, pubMLST integrates third-party tools to perform multiple steps for WGS analysis (i.e. strain typing, core-genome MLST, genome comparison, AMR prediction and network analysis) but lacks data cleaning, assembly and scaffolding processes. The development of novel user-friendly frameworks, particularly for those with limited bioinformatics skills, would facilitate the more widespread N. gonorrhoeae WGS applications in both clinical and research settings.

Key Points

  • All (n = 105) published Neisseria gonorrhoeae WGS studies (as of 30 April 2021) were reviewed.

  • Computational databases and analytical tools used for N. gonorrhoeae WGS data analysis were summarized.

  • Analytical resources for strain typing (i.e. NG-MAST, MLST and NG-STAR) and antimicrobial resistance determination for N. gonorrhoeae WGS data were reviewed.

  • Analytical limitations (e.g. missing information, split genes or contaminating reads from closely related species/strains) of some tools were identified.

  • Only a few computations pipelines for N. gonorrhoeae WGS analysis are available. The development of more user-friendly bioinformatics tools and algorithms would facilitate the analysis of WGS data from N. gonorrhoeae, especially for clinical diagnostic settings.

Supplementary Material

SupplementaryTable1_elab028
SupplementaryTable2_elab028
SupplementaryTable3_elab028

Reema Singh is a Postdoctoral Fellow in the Department of Biochemistry, Microbiology and Immunology (College of Medicine) at the University of Saskatchewan.

Anthony Kusalik is a Professor in the Department of Computer Science at the University of Saskatchewan. He is also the Director of the Bioinformatics Program at the University of Saskatchewan.

Jo-Anne R. Dillon is a Distinguished Professor in the Department of Biochemistry, Microbiology and Immunology (College of Medicine) at the University of Saskatchewan. She is also a Research Scientist at the Vaccine and Infectious Disease Organization.

Contributor Information

Reema Singh, Department of Biochemistry, Microbiology and Immunology.

Anthony Kusalik, Department of Computer Science at the University of Saskatchewan.

Jo-Anne R Dillon, Department of Biochemistry Microbiology and Immunology, College of Medicine, c/o Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Saskatchewan S7N5E3, Canada.

Acknowledgments

This manuscript is published with the permission of the Director of VIDO-InterVac as journal series no. 928.

Funding

This work was partially supported by funding from the Canadian Institutes of Health Research (grant # 148996 to JRD).

References

  • 1. Rowley  J, Vander Hoorn  S, Korenromp  E, et al.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ  2019;97(8):548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Unemo  M, Seifert  HS, Hook  EW, et al.  Gonorrhoea. Nat Rev Dis Primers  2019;5(1):1–23. [DOI] [PubMed] [Google Scholar]
  • 3. Sánchez-Busó  L, Harris  SR. Using genomics to understand antimicrobial resistance and transmission in Neisseria gonorrhoeae. Microb Genom  2019;5(2):e000239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Wi  T, Lahra  MM, Ndowa  F, et al.  Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action. PLoS Med.  2017;14(7):e1002344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bodie  M, Gale-Rowe  M, Alexandre  S, et al.  Multidrug resistant gonorrhea: addressing the rising rates of gonorrhea and drug-resistant gonorrhea: there is no time like the present. Can Commun Dis Rep  2019;45(2–3):54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Town  K, Bolt  H, Croxford  S, et al.  Neisseria gonorrhoeae molecular typing for understanding sexual networks and antimicrobial resistance transmission: a systematic review. J Infect  2018;76(6):507–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Mortimer  TD, Grad  YH. Applications of genomics to slow the spread of MDR Neisseria gonorrhoeae. Ann N Y Acad Sci  2019;1435(1):93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Unemo  M, Dillon  JA. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev  2011;24(3):447–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Kahler  CM. The goldilocks zone: searching for a phylogenetic approach for the recombinogenic Neisseria gonorrhoeae. J Infect Dis  2020;222(11):1762–3. [DOI] [PubMed] [Google Scholar]
  • 10. Harrison  OB, Schoen  C, Retchless  AC, et al.  Neisseria genomics: current status and future perspectives. Pathog Dis  2017;75(6):ftx060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Cock  PJ, Fields  CJ, Goto  N, et al.  The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res  2010;38(6):1767–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Andrew  S. https://github.com/s-andrews/FastQC (3 September 2020, date last accessed).
  • 13. Chen  S, Zhou  Y, Chen  Y, et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics  2018;34(17):i884–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Patel  RK, Jain  M. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data. PLoS ONE  2012;7(2):e30619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Schmieder  R, Edwards  R. Quality control and preprocessing of metagenomic datasets. Bioinformatics  2011;27(6):863–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lee  RS, Seemann  T, Heffernan  H, et al.  Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand. J Antimicrob Chemoth  2018;73:353–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Parmar  NR, Singh  R, Martin  I, et al.  Genomic analysis reveals antibiotic susceptible clones and emerging resistance in Neisseria gonorrhoeae (Saskatchewan, Canada). Antimicrob Agents Chemother  2020;64(9):e02514–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Demczuk  W, Lynch  T, Martin  I, et al.  Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol  2015;53(1):191–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Demczuk  W, Martin  I, Peterson  S, et al.  Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol  2016;54(5):1304–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Gianecini  RA, Zittermann  S, Oviedo  C, et al.  Use of whole genome sequencing for the molecular comparison of Neisseria gonorrhoeae isolates with decreased susceptibility to extended spectrum cephalosporins from 2 geographically different regions in America. J Sex Transm Dis  2019;46(8):548–55. [DOI] [PubMed] [Google Scholar]
  • 21. Thomas  JC, Seby  S, Abrams  AJ, et al.  Evidence of recent genomic evolution in gonococcal strains with decreased susceptibility to cephalosporins or azithromycin in the United States, 2014–2016. J Infect Dis  2019;220(2):294–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Buckley  C, Forde  BM, Trembizki  E, et al.  Use of whole genome sequencing to investigate an increase in Neisseria gonorrhoeae infection among women in urban areas of Australia. Sci Rep  2018;8(1):1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Kubanov  AA, Runina  AV, Chestkov  AV, et al.  Whole-genome sequencing of Russian Neisseria gonorrhoeae isolates related to ST 1407 genogroup. Acta Naturae  2018;10(3):68–76. [PMC free article] [PubMed] [Google Scholar]
  • 24. Peng  JP, Yin  YP, Chen  SC, et al.  A whole-genome sequencing analysis of Neisseria gonorrhoeae isolates in China: an observational study. EClinicalMedicine  2019;7:47–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Harris  SR, Cole  MJ, Spiteri  G, et al.  Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey. Lancet Infect Dis  2018;18:758–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kwong  JC, Chow  EPF, Stevens  K, et al.  Whole-genome sequencing reveals transmission of gonococcal antibiotic resistance among men who have sex with men: an observational study. Sex Trans Infect  2018;94:151–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Ezewudo  MN, Joseph  SJ, Castillo-Ramirez  S, et al.  Population structure of Neisseria gonorrhoeae based on whole genome data and its relationship with antibiotic resistance. PeerJ  2015;3:e806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Carannante  A, Ciammaruconi  A, Vacca  P, et al.  Genomic characterization of gonococci from different anatomic sites, Italy, 2007–2014. Microb Drug Resist  2019;25(9):1316–24. [DOI] [PubMed] [Google Scholar]
  • 29. Pinto  M, Matias  R, Rodrigues  JC, et al.  Cephalosporin-resistant Neisseria gonorrhoeae isolated in Portugal, 2019. Sex Transm Dis  2020;47(11):e54–6. [DOI] [PubMed] [Google Scholar]
  • 30. Francés-Cuesta  C, de la  Caba  I, Idigoras  P, et al.  Whole-genome sequencing of Neisseria gonorrhoeae in a forensic transmission case. Forensic Sci Int Genet  2019;42:141–6. [DOI] [PubMed] [Google Scholar]
  • 31. Cornelisse  VJ, Williamson  D, Zhang  L, et al.  Evidence for a new paradigm of gonorrhoea transmission: cross-sectional analysis of Neisseria gonorrhoeae infections by anatomical site in both partners in 60 male couples. Sex Trans Infect  2019;95(6):437–42. [DOI] [PubMed] [Google Scholar]
  • 32. Maduna  LD, Kock  MM, van der  Veer  BM, et al.  Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk men in Johannesburg. South Africa. Antimicrob Agents Chemother  2020;64(11):e00906–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Liu  H, Vidyaprakash  E, Schmerer  MW, et al.  A culture collection of 50 Neisseria gonorrhoeae isolates. Microbiol Resour Announc  2020;9(40):e00699–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Fiore  MA, Raisman  JC, Wong  NH, et al.  Exploration of the Neisseria resistome reveals resistance mechanisms in commensals that may be acquired by N. gonorrhoeae through horizontal gene transfer. Antibiotics  2020;9(10):656. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Gernert  KM, Seby  S, Schmerer  MW, et al.  Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: a genomic analysis of surveillance data. Lancet Microbe  2020;1(4):e154–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Sánchez-Busó  L, Yeats  CA, Taylor  B, et al.  A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Med  2021;13(1):61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Ashcroft  MM, Chow  EP, Lee  DY, et al.  Genomic assessment of within-host population variation in Neisseria gonorrhoeae: implications for gonorrhoea transmission. MedRxiv. 2020; 2020.08.24.20181230. doi: 10.1101/2020.08.24.20181230. [DOI]
  • 38. de  Block  T, Laumen  JG, Van Dijck  C, et al.  WGS of commensal Neisseria reveals acquisition of a new ribosomal protection protein (MsrD) as a possible explanation for high level azithromycin resistance in Belgium. Pathogens  2021;10(3):384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Asmerom  B, Drobish  I, Winckler  B, et al.  Detection of Neisseria gonorrhoeae from joint aspirate by metagenomic sequencing in disseminated gonococcal infection. J Pediatric Infect Dis Soc  2021;10(3):367–9. [DOI] [PubMed] [Google Scholar]
  • 40. Mortimer  TD, Pathela  P, Crawley  A, et al.  The distribution and spread of susceptible and resistant Neisseria gonorrhoeae across demographic groups in a major metropolitan center. Clin Infect Dis  2020;ciaa1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Holderman  JL, Thomas  JC, Schlanger  K, et al.  Sustained transmission of Neisseria gonorrhoeae with high-level resistance to azithromycin, in Indianapolis, Indiana, 2017–2018. Clin Infect Dis  2021;ciab132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. de  Korne-Elenbaas  J, Bruisten  SM, de  Vries  HJ, et al.  Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis. J Antimicrob Chemother  2021;dkab082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Palavecino  EL, Kilic  A, Schmerer  MW, et al.  First case of high-level azithromycin-resistant Neisseria gonorrhoeae in North Carolina. Sex Transm Dis  2020;47(5):326–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Valiente-Mullor  C, Beamud  B, Ansari  I, et al.  One is not enough: on the effects of reference genome for the mapping and subsequent analyses of short-reads. PLoS Comput Biol  2021;17(1):e1008678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Pinto  M, Borges  V, Isidro  J, et al.  Neisseria gonorrhoeae clustering to reveal major European whole-genome-sequencing-based genogroups in association with antimicrobial resistance. Microb Genom  2021;7(2):000481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Schmerer  MW, Abrams  AJ, Seby  S, et al.  Genomic characterization of Neisseria gonorrhoeae strains from 2016 US Sentinel Surveillance displaying reduced susceptibility to azithromycin. J Antimicrob Chemother  2020;64(5):e2420–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Cherdtrakulkiat  T, Wongsurawat  T, Jenjaroenpun  P, et al.  Complete genome sequences of three Neisseria gonorrhoeae isolates from Thailand with multidrug resistance and multilocus sequence type 1903. Microbiol Resour Announc  2020;9(19):e00198–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Singh  R, Dillon  JAR, Demczuk  W, et al.  Gen2Epi: an automated whole-genome sequencing pipeline for linking full genomes to antimicrobial susceptibility and molecular epidemiological data in Neisseria gonorrhoeae. BMC Genomics  2019;20:165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Ma  KC, Mortimer  TD, Hicks  AL, et al.  Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae. Nat Commun  2020;11(1):4126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Unemo  M, Golparian  D, Sánchez-Busó  L, et al.  The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother  2016;71(11):3096–108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Singh  R, Yarmovich  T, Kusalik  A, et al.  Gen2EpiGUI: user-friendly pipeline for analyzing whole genome sequencing data for epidemiological studies of Neisseria gonorrhoeae. Sex Transm Dis  2020;47(10):e42–4. [DOI] [PubMed] [Google Scholar]
  • 52. Seemann  T. https://github.com/tseemann/nullarbor (3 September 2020, date last accessed).
  • 53. Machado  MP, Halkilahti  J, Jaakkonen  A. et al.  INNUca GitHub . https://github.com/B-UMMI/INNUca (4 September 2020, date last accessed). [Google Scholar]
  • 54. Del Fabbro  C, Scalabrin  S, Morgante  M, et al.  An extensive evaluation of read trimming effects on Illumina NGS data analysis. PloS one  2013;8(12):e85024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Bolger  AM, Lohse  M, Usadel  B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics  2014;30(15):2114–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Martin  M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet  2011;17(1):10–2. [Google Scholar]
  • 57. Smeds  L, Künstner  A. ConDeTri-a content dependent read trimmer for Illumina data. PloS One  2011;6(10):e26314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Cox  MP, Peterson  DA, Biggs  PJ. SolexaQA: at-a-glance quality assessment of Illumina second-generation sequencing data. BMC Bioinformatics  2010;11(1):1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Krueger  F. https://github.com/FelixKrueger/TrimGalore (4 September 2020, date last accessed).
  • 60. Bailey  AL, Potter  RF, Wallace  MA, et al.  Genotypic and phenotypic characterization of antimicrobial resistance in Neisseria gonorrhoeae: a cross-sectional study of isolates recovered from routine urine cultures in a high-incidence setting. Msphere  2019;4(4):e00373–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Alfsnes  K, Eldholm  V, Olsen  AO, et al.  Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016–2017. Microb Genom  2020;6(4):e000359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Williamson  DA, Chow  EP, Gorrie  CL, et al.  Bridging of Neisseria gonorrhoeae lineages across sexual networks in the HIV pre-exposure prophylaxis era. Nat Commun  2019;10(1):3988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Wang  H, Wang  Y, Yong  G, et al.  Emergence and genomic characterization of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in Chengdu, China. J Antimicrob Chemother  2020;75(9):2495–8. [DOI] [PubMed] [Google Scholar]
  • 64. Miyake  H, Mitobe  M, Kubota  H, et al.  Complete genome sequence of ceftriaxone-resistant Neisseria gonorrhoeae SS3160, isolated in Tokyo, Japan. Microbiol Resour Announc  2020;9(39):e00886–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Kivata  MW, Mbuchi  M, Eyase  F, et al.  Plasmid mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates from Kenya. BMC Infect Dis  2020;20(1):703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Banhart  S, Selb  R, Oehlmann  S, et al.  The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018. J Infect Dis  2021;jiab091. [DOI] [PubMed] [Google Scholar]
  • 67. Zhang  C, Wang  F, Zhu  C, et al.  Determining antimicrobial resistance profiles and identifying novel mutations of Neisseria gonorrhoeae genomes obtained by multiplexed MinION sequencing. Sci China Life Sci  2020;63(7):1063–70. [DOI] [PubMed] [Google Scholar]
  • 68. Mitchev  N, Allam  M, Kwenda  S, et al.  Genome sequences of five novel Neisseria gonorrhoeae sequence types isolated in KwaZulu-Natal, South Africa. Microbiol Resour Announc  2021;10(9):e01424–0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Murphy  TC, Mortimer  TD, Nicholas  RA, et al.  Draft genome sequences of three penicillin-resistant Neisseria gonorrhoeae strains isolated in Cincinnati, Ohio, in 1994. Microbiol Resour Announc  2021;10(11):e00074–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Salmerón  P, Moreno-Mingorance  A, Trejo  J, et al.  Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016–18. J Antimicrob Chemother  2021;76(4):930–5. [DOI] [PubMed] [Google Scholar]
  • 71. Wood  DE, Salzberg  SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol  2014;15(3):R46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Schmieder  R, Edwards  R. Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PloS One  2011;6(3):e17288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Truong  DT, Franzosa  EA, Tickle  TL, et al.  MetaPhylA2 for enhanced metagenomic taxonomic profiling. Nature Methods  2015;12:902–3. [DOI] [PubMed] [Google Scholar]
  • 74. Hasman  H, Saputra  D, Sicheritz-Ponten  T, et al.  Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J Clin Microbiol  2014;52(1):139–46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Larsen  MV, Cosentino  S, Lukjancenko  O, et al.  Benchmarking of methods for genomic taxonomy. J Clin Microbiol  2014;52(5):1529–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Low  AJ, Koziol  AG, Manninger  PA, et al.  ConFindr: rapid detection of intraspecies and cross-species contamination in bacterial whole-genome sequence data. PeerJ  2019;7:e6995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Boiko  I, Golparian  D, Jacobsson  S, et al.  Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013-2018. APMIS  2020;128(7):465–75. [DOI] [PubMed] [Google Scholar]
  • 78. Golparian  D, Harris  SR, Sánchez-Busó  L, et al.  Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928–2013): antimicrobial use/misuse selects for resistance and drives evolution. BMC Genomics  2020;21(1):116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Town  K, Field  N, Harris  SR, et al.  Phylogenomic analysis of Neisseria gonorrhoeae transmission to assess sexual mixing and HIV transmission risk in England: a cross-sectional, observational, whole-genome sequencing study. Lancet Infect Dis  2020;20(4):478–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Hardick  J, Crowell  TA, Lombardi  K, et al.  Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women. Int J STD AIDS  2018;29(13):1273–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Graham  RM, Doyle  CJ, Jennison  AV. Epidemiological typing of Neisseria gonorrhoeae and detection of markers associated with antimicrobial resistance directly from urine samples using next generation sequencing. Sex Transm Infect  2017;93(1):65–7. [DOI] [PubMed] [Google Scholar]
  • 82. Bankevich  A, Nurk  S, Antipov  D, et al.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comp Biol  2012;19(5):455–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Zerbino  DR. Using the Velvet de novo assembler for short-read sequencing technologies. Curr Protoc Bioinformatics  2010;31(1):11–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Simpson  JT, Wong  K, Jackman  SD, et al.  ABySS: a parallel assembler for short read sequence data. Genome Res  2009;19(6):1117–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Wick  RR, Judd  LM, Gorrie  CL, et al.  Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol  2017;13(6):e1005595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Peng  Y, Leung  HC, Yiu  SM, et al.  IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth. Bioinformatics  2012;28(11):1429–8. [DOI] [PubMed] [Google Scholar]
  • 87. Page  AJ, De Silva  N, Hunt  M, et al.  Robust high-throughput prokaryote de novo assembly and improvement pipeline for Illumina data. Microb Genom  2016;2(8):e000083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Al Suwayyid  BA, Coombs  GW, Speers  DJ, et al.  Genomic epidemiology and population structure of Neisseria gonorrhoeae from remote highly endemic Western Australian populations. BMC Genomics  2018;19(1):165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Lahra  MM, Martin  I, Demczuk  W, et al.  Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain. Emerg Infect Dis  2018;24(4):735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Wind  CM, de  Vries  E, Schim van der Loeff  MF, et al.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae isolates in patients recently treated with azithromycin. Clin Infect Dis  2017;65(1):37–45. [DOI] [PubMed] [Google Scholar]
  • 91. Fifer  H, Cole  M, Hughes  G, et al.  Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study. Lancet Infect Dis  2018;18(5):573–81. [DOI] [PubMed] [Google Scholar]
  • 92. Ryan  L, Golparian  D, Fennelly  N, et al.  Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014–2016: focus on extended-spectrum cephalosporins and azithromycin. Eur J Clin Microbiol Infect Dis  2018;37(9):1661–72. [DOI] [PubMed] [Google Scholar]
  • 93. Palace  SG, Wang  Y, Rubin  DH, et al.  RNA polymerase mutations cause cephalosporin resistance in clinical Neisseria gonorrhoeae isolates. Elife  2020;9:e51407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Chisholm  SA, Wilson  J, Alexander  S, et al.  An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England. Sex Trans Infect  2016;92(5):365–7. [DOI] [PubMed] [Google Scholar]
  • 95. Poncin  T, Merimeche  M, Braille  A, et al.  Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019. Euro Surveill  2019;24(36):1900528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96. Poncin  T, Fouere  S, Braille  A, et al.  Multidrug-resistant Neisseria gonorrhoeae failing treatment with ceftriaxone and doxycycline in France, November 2017. Euro Surveill  2018;23(21):1800264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Vidyaprakash  E, Abrams  AJ, Shafer  WM, et al.  Whole-genome sequencing of a large panel of contemporary Neisseria gonorrhoeae clinical isolates indicates that a wild-type mtrA gene is common: implications for inducible antimicrobial resistance. Antimicrob Agents Chemother  2017;61(4):e00262–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Hicks  AL, Kissler  SM, Lipsitch  M, et al.  Surveillance to maintain the sensitivity of genotype-based antibiotic resistance diagnostics. PLoS Biology  2019;17(11):e3000547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Papp  JR, Abrams  AJ, Nash  E, et al.  Azithromycin resistance and decreased ceftriaxone susceptibility in Neisseria gonorrhoeae, Hawaii, USA. Emerg Infect Dis  2017;23(5):830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Hicks  AL, Kissler  SM, Mortimer  TD, et al.  Targeted surveillance strategies for efficient detection of novel antibiotic resistance variants. eLife  2020;9:e56367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Osnes  MN, Van Dorp  L, Brynildsrud  OB, et al.  Antibiotic treatment regimes as a driver of the global population dynamics of a major gonorrhea lineage. Mol Biol Evol  2021;38(4):1249–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Osnes  MN, Didelot  X, Korne-Elenbaas  JD, et al.  Sudden emergence of a Neisseria gonorrhoeae clade with reduced susceptibility to extended-spectrum cephalosporins, Norway. Microb Genom  2020;6(12):e000480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Yahara  K, Ma  KC, Mortimer  TD, et al.  Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae. Genome Med  2021;13(1):51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104. Hicks  AL, Wheeler  N, Sánchez-Busó  L, et al.  Evaluation of parameters affecting performance and reliability of machine learning-based antibiotic susceptibility testing from whole genome sequencing data. PLoS Comput Biol  2019;15(9):e1007349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105. Ma  KC, Mortimer  TD, Duckett  MA, et al.  Increased power from conditional bacterial genome-wide association identifies macrolide resistance mutations in Neisseria gonorrhoeae. Nat Commun  2020;11(1):5374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Grad  YH, Kirkcaldy  RD, Trees  D, et al.  Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis  2014;14(3):220–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107. Grad  YH, Harris  SR, Kirkcaldy  RD, et al.  Genomic epidemiology of gonococcal resistance to extended-spectrum cephalosporins, macrolides, and fluoroquinolones in the United States, 2000–2013. J Infect Dis  2016;214(10):1579–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108. De Silva  D, Peters  J, Cole  K, et al.  Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study. Lancet Infect Dis  2016;16(11):1295–303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109. Terkelsen  D, Tolstrup  J, Johnsen  CH, et al.  Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill  2017;22(42):17–00659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Harrison  OB, Clemence  M, Dillard  JP, et al.  Genomic analyses of Neisseria gonorrhoeae reveal an association of the gonococcal genetic island with antimicrobial resistance. J Infect  2016;73(6):578–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Harrison  OB, Cehovin  A, Skett  J, et al.  Neisseria gonorrhoeae population genomics: use of the gonococcal core genome to improve surveillance of antimicrobial resistance. J Infect Dis  2020;222(11):1816–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Cehovin  A, Jolley  KA, Maiden  MC, et al.  Association of Neisseria gonorrhoeae plasmids with distinct lineages and the economic status of their country of origin. J Infect Dis  2020;222(11):1826–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Eyre  DW, De Silva  D, Cole  K, et al.  WGS to predict antibiotic MICs for Neisseria gonorrhoeae. J Antimicrob Chemother  2017;72(7):1937–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Jacobsson  S, Golparian  D, Cole  M, et al.  WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC> 2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014. J Antimicrob Chemother  2016;71(11):3109–16. [DOI] [PubMed] [Google Scholar]
  • 115. da  Costa-Lourenço  AP, Abrams  AJ, Dos Santos  KT, et al.  Phylogeny and antimicrobial resistance in Neisseria gonorrhoeae isolates from Rio de Janeiro, Brazil. Infect Genet Evol  2018;58:157–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116. Golparian  D, Rose  L, Lynam  A, et al.  Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill  2018;23(47):1800617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117. Lee  K, Nakayama  SI, Osawa  K, et al.  Clonal expansion and spread of the ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, identified in Japan in 2015, and closely related isolates. J Antimicrob Chemother  2019;74(7):1812–9. [DOI] [PubMed] [Google Scholar]
  • 118. Lan  PT, Golparian  D, Ringlander  J, et al.  Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015–16. J Antimicrob Chemother  2020;75(6):1432–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Golparian  D, Bazzo  ML, Golfetto  L, et al.  Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015–16. J Antimicrob Chemother  2020;75(11):3163–72. [DOI] [PubMed] [Google Scholar]
  • 120. Vidovic  S, Caron  C, Taheri  A, et al.  Using crude whole-genome assemblies of Neisseria gonorrhoeae as a platform for strain analysis: clonal spread of gonorrhea infection in Saskatchewan, Canada. J Clin Microbiol  2014;52(10):3772–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121. Gianecini  RA, Golparian  D, Zittermann  S, et al.  Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011–16. J Antimicrob Chemother  2019;74(6):1551–9. [DOI] [PubMed] [Google Scholar]
  • 122. Laumen  JG, Basil  SM, Verhoeven  E, et al.  Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae. J Antimicrob Chemother  2021;dkab084. [DOI] [PubMed] [Google Scholar]
  • 123. Eyre  DW, Town  K, Street  T, et al.  Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018. Euro Surveill  2019;24(10):1900147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Eyre  DW, Sanderson  ND, Lord  E, et al.  Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill  2018;23(27):1800323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125. Brynildsrud  OB, Osnes  MN, Ma  KC, et al.  High-frequency phase-switching of modB methylase is associated with phenotypic ceftriaxone susceptibility in Neisseria gonorrhoeae. BioRxiv. 2020; 2020.04.13.040246. doi: 10.1101/2020.04.13.040246. [DOI]
  • 126. Sánchez-Busó  L, Golparian  D, Corander  J, et al.  The impact of antimicrobials on gonococcal evolution. Nat Microbiol  2019;4(11):1941–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Hess  D, Wu  A, Golparian  D, et al.  Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother  2012;56(11):5633–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. de  Curraize  C, Kumanski  S, Micaëlo  M, et al.  Ceftriaxone-resistant Neisseria gonorrhoeae isolates (2010 to 2014) in France characterized by using whole-genome sequencing. Antimicrob Agents Chemother  2016;60(11):6962–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129. Didelot  X, Dordel  J, Whittles  LK, et al.  Genomic analysis and comparison of two gonorrhea outbreaks. MBio  2016;7(3):e00525–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130. Yahara  K, Nakayama  SI, Shimuta  K, et al.  Genomic surveillance of Neisseria gonorrhoeae to investigate the distribution and evolution of antimicrobial-resistance determinants and lineages. Microb Genom  2018;4(8):e000205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Johnson  SR, Grad  Y, Abrams  AJ, et al.  Use of whole-genome sequencing data to analyze 23S rRNA-mediated azithromycin resistance. Int J Antimicrob Agents  2017;49(2):252–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Soge  OO, Salipante  SJ, No  D, et al.  In vitro activity of delafloxacin against clinical Neisseria gonorrhoeae isolates and selection of gonococcal delafloxacin resistance. Antimicrob Agents Chemother  2016;60(5):3106–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133. Jennison  AV, Whiley  D, Lahra  MM, et al.  Genetic relatedness of ceftriaxone-resistant and high-level azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018. Euro Surveill  2019;24(8):1900118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134. Chen  SC, Yuan  LF, Zhu  XY, et al.  Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China. J Antimicrob Chemother  2020;75(9):2499–502. [DOI] [PubMed] [Google Scholar]
  • 135. Demczuk  W, Martin  I, Sawatzky  P, et al.  Equations to predict antimicrobial MICs in Neisseria gonorrhoeae using molecular antimicrobial resistance determinants. Antimicrob Agents Chemother  2020;64(3):e02005–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136. Peters  J, Cresswell  F, Amor  L, et al.  Whole genome sequencing of Neisseria gonorrhoeae reveals transmission clusters involving patients of mixed HIV serostatus. Sex Trans Infect  2018;94(2):138–43. [DOI] [PubMed] [Google Scholar]
  • 137. Peterson  SW, Martin  I, Demczuk  W, et al.  Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples. J Antimicrob Chemother  2020;75(12):3485–90. [DOI] [PubMed] [Google Scholar]
  • 138. Liang  JY, Jiang  YQ, Cao  WL, et al.  More mutation accumulation in Neisseria gonorrhoeae (NG) with susceptibility than that in NG with decreased susceptibility to ceftriaxone. Chin Med J  2020;133(13):1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139. Golparian  D, Sánchez-Busó  L, Cole  M, et al.  Neisseria gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions. J Antimicrob Chemother  2021;76(4):940–4. [DOI] [PubMed] [Google Scholar]
  • 140. Unemo  M, Ahlstrand  J, Sánchez-Busó  L, et al.  High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. J Antimicrob Chemother  2021;76(5):1221–8. [DOI] [PubMed] [Google Scholar]
  • 141. Ogbebor  O, Mortimer  TD, Fryling  K, et al.  Disseminated gonococcal infection complicated by prosthetic joint infection: case report and genomic and phylogenetic analysis. Open Forum Infect Dis  2020;8(2):ofaa632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142. Yan  J, Chen  Y, Yang  F, et al.  High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China. J Antimicrob Chemother  2021;76(4):936–9. [DOI] [PubMed] [Google Scholar]
  • 143. Al Suwayyid  BA, Rankine-Wilson  L, Speers  DJ, et al.  Meningococcal disease-associated prophage-like elements are present in Neisseria gonorrhoeae and some commensal Neisseria species. Genome Biol Evol  2020;12(2):3938–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144. Chung  GT, Yoo  JS, Oh  HB, et al.  Complete genome sequence of Neisseria gonorrhoeae NCCP11945. J Bacteriol  2008;190(17):6035–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145. Ghurye  J, Pop  M. Modern technologies and algorithms for scaffolding assembled genomes. PloS Comput Biol  2019;15(6):e1006994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146. Parmar  N, Singh  R, Martin  I, et al.  P644 Analyzing the genomes of Neisseria gonorrhoeae isolates using a novel integrated bioinformatic pipeline: Gen2Epi. Sex Trans Infect  2019;95(Suppl_1):A284. [Google Scholar]
  • 147. Sanderson  ND, Swann  J, Barker  L, et al.  High precision Neisseria gonorrhoeae variant and antimicrobial resistance calling from metagenomic Nanopore sequencing. Genome Res  2020;30(9):1354–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148. Gurevich  A, Saveliev  V, Vyahhi  N, et al.  QUAST: quality assessment tool for genome assemblies. Bioinformatics  2013;29(8):1072–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149. Seemann  T. https://github.com/tseemann/prokka (3 September 2020, date last accessed).
  • 150. Hyatt  D, Chen  GL, LoCascio  PF, et al.  Prodigal: prokaryotic gene recognition and translation initiation site identification. BMC Bioinformatics  2010;11(1):119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151. Tatusova  T, DiCuccio  M, Badretdin  A, et al.  NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res  2016;44(14):6614–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152. Tanizawa  Y, Fujisawa  T, Nakamura  Y. DFAST: a flexible prokaryotic genome annotation pipeline for faster genome publication. Bioinformatics  2018;34(6):1037–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153. Li  H, Durbin  R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics  2009;25(14):1754–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154. Langmead  B, Trapnell  C, Pop  M, et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol  2009;10(3):R25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155. Lunter  G, Goodson  M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res  2011;21(6):936–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156. MarBL . https://github.com/marbl/parsnp (3 September 2020, date last accessed).
  • 157. Petkau  A, Mabon  P, Sieffert  C, et al.  SNVPhyl: a single nucleotide variant phylogenomics pipeline for microbial genomic epidemiology. Microb Genom  2017;3(6):e000116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158. Seemann  T. https://github.com/tseemann/snippy (4 September 2020, date last accessed).
  • 159. Callahan  R. https://www.sanger.ac.uk/tool/smalt-0 (4 September 2020, date last accessed).
  • 160. Schubert  B, Maddamsetti  R, Nyman  J, et al.  Genome-wide discovery of epistatic loci affecting antibiotic resistance in Neisseria gonorrhoeae using evolutionary couplings. Nat Microbiol  2019;4(2):328–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161. Li  H, Handsaker  B, Wysoker  A, et al.  The sequence alignment/map format and SAMtools. Bioinformatics  2009;25(16):2078–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162. Broad Institute . https://github.com/broadinstitute/gatk (3 September 2020, date last accessed).
  • 163. Walker  BJ, Abeel  T, Shea  T, et al.  Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PloS one  2014;9(11):e112963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164. Ning  Z, Cox  AJ, Mullikin  JC. SSAHA: a fast search method for large DNA databases. Genome Res  2001;11(10):1725–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165. Garrison  E, Marth  G. Haplotype-based variant detection from short-read sequencing. arXiv. 2012; 1207.3907. https://arxiv.org/abs/1207.3907(2012).
  • 166. Page  AJ, Cummins  CA, Hunt  M, et al.  Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics  2015;31(22):3691–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167. Jolley  KA, Maiden  MC. Automatic extraction of typing information for bacterial pathogens from whole genome sequence data: Neisseria meningitidis as an exemplar. Euro Surveill  2013;18(4):20379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168. Martin  IMC, Ison  CA, Aanensen  DM, et al.  Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis  2004;189(8):1497–505. [DOI] [PubMed] [Google Scholar]
  • 169. Demczuk  W, Sidhu  S, Unemo  M, et al.  Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. gonorrhoeae strains. J Clin Microbiol  2017;55:1454–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170. Kwong  JC, da  Silva  AG, Dyet  K, et al.  NGMASTER: in silico multi-antigen sequence typing for Neisseria gonorrhoeae. Microb Genom  2016;2(8):e000076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171. Inouye  M, Conway  TC, Zobel  J, et al.  Short read sequence typing (SRST): multi-locus sequence types from short reads. BMC Genomics  2012;13(1):338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 172. Jolley  KA, Maiden  MCJ. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics  2010;11:595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 173. Jolley  KA, Chan  MS, Maiden  MC. mlstdbNet–distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics  2004;5(1):86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 174. Hunt  M, Mather  AE, Sánchez-Busó  L, et al.  ARIBA: rapid antimicrobial resistance genotyping directly from sequencing reads. Microb Genom  2017;3(10):e000131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175. Seemann  T. https://github.com/tseemann/mlst (3 September 2020, date last accessed).
  • 176. Alcock  BP, Raphenya  AR, Lau  TT, et al.  CARD 2020: antibiotic resistome surveillance with the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res  2020;48(D1):D517–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177. Wattam  AR, Abraham  D, Dalay  O, et al.  PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res  2014;42:D581–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178. Thai  QK, Bös  F, Pleiss  J. The Lactamase Engineering Database: a critical survey of TEM sequences in public databases. BMC Genomics  2009;10:390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179. Gupta  SK, Padmanabhan  BP, Diene  SM, et al.  ARG-ANNOT, a new bioinformatics tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother  2014;58(1):212–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180. Davis  JJ, Boisvert  S, Brettin  T, et al.  Antimicrobial resistance prediction in PATRIC and RAST. Sci Rep  2016;6:27930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181. Zankari  E, Hasman  H, Cosentino  S, et al.  Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother  2012;67(11):2640–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182. Seemann  T. https://github.com/tseemann/abricate (4 September 2020, date last accessed).
  • 183. Kivata  MW, Mbuchi  M, Eyase  FL, et al.  gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya. BMC Microbiol  2019;19(1):76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 184. Ang  GY, Yu  CY, Yong  DA, et al.  Draft genome sequence of Neisseria gonorrhoeae strain NG_869 with penicillin, tetracycline and ciprofloxacin resistance determinants isolated from Malaysia. Indian J Microbiol  2016;56(2):225–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185. Marri  PR, Paniscus  M, Weyand  NJ, et al.  Genome sequencing reveals widespread virulence gene exchange among human Neisseria species. PLoS One  2010;5(7):e11835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186. Muhammad  I, Golparian  D, Dillon  JA, et al.  Characterisation of bla TEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae–the prevalent and conserved bla TEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect Dis  2014;14(1):454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187. Stefanelli  P, Carannante  A, Bonanno  CL, et al.  Molecular characterization of Penicillinase–producing Neisseria gonorrhoeae isolated in two time periods, 2003–2004 and 2014–2015, in Italy. Microb Drug Resist  2018;24(5):621–6. [DOI] [PubMed] [Google Scholar]
  • 188. Town  K, Harris  S, Sánchez-Busó  L, et al.  Genomic and phenotypic variability in Neisseria gonorrhoeae antimicrobial susceptibility, England. Emerg Infect Dis  2020;26(3):505–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189. Zankari  E, Allesøe  R, Joensen  KG, et al.  PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother  2017;72(10):2764–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190. Shi  J, Yan  Y, Links  MG, et al.  Antimicrobial resistance genetic factor identification from whole-genome sequence data using deep feature selection. BMC Bioinformatics  2019;20(15):1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 191. Li  X, Lin  J, Hu  Y, et al.  PARMAP: a Pan-Genome-based computational framework for predicting antimicrobial resistance. Front Microbiol  2020;11:578795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192. Bush  K, Jacoby  GA, Medeiros  AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother  1995;39(6):1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 193. Bush  K, Jacoby  GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother  2010;54(3):969–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194. Singh  R, Perera  SR, Katselis  GS, et al.  A β-lactamase-producing plasmid from Neisseria gonorrhoeae carrying a unique 6 bp deletion in bla TEM-1 encoding a truncated 24 kDa TEM-1 penicillinase that hydrolyses ampicillin slowly. J Antimicrob Chemoth  2019;74(10):2904–12. [DOI] [PubMed] [Google Scholar]
  • 195. Vigue  L, Eyre-Walker  A. The comparative population genetics of Neisseria meningitidis and Neisseria gonorrhoeae. PeerJ  2019;7:e7216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196. Schierup  MH, Hein  J. Consequences of recombination on traditional phylogenetic analysis. Genetics  2000;156(2):879–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 197. Croucher  NJ, Page  AJ, Connor  TR, et al.  Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res  2015;43(3):e15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198. Didelot  X, Falush  D. Inference of bacterial microevolution using multilocus sequence data. Genetics  2007;175(3):1251–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199. Didelot  X, Wilson  DJ. ClonalFrameML: efficient inference of recombination in whole bacterial genomes. PLoS Comput Biol  2015;11(2):e1004041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200. Stamatakis  A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics  2014;30(9):1312–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 201. Guindon  S, Lethiec  F, Duroux  P, et al.  PHYML Online—a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res  2005;33(suppl_2):W557–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202. Hall  BG. Building phylogenetic trees from molecular data with MEGA. Mol Biol Evol  2013;30(5):1229–35. [DOI] [PubMed] [Google Scholar]
  • 203. Price  MN, Dehal  PS, Arkin  AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol  2009;26(7):1641–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 204. Nguyen  LT, Schmidt  HA, Von Haeseler  A, et al.  IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol  2015;32(1):268–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 205. Suchard  MA, Lemey  P, Baele  G, et al.  Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol  2018;4(1):vey016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 206. Ropelewski  AJ, Nicholas  HB, Jr, Mendez  RR. MPI-PHYLIP: parallelizing computationally intensive phylogenetic analysis routines for the analysis of large protein families. PloS One  2010;5(11):e13999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 207. Francisco  AP, Vaz  C, Monteiro  PT, et al.  PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics  2012;13(1):87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 208. Letunic  I, Bork  P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics  2007;23(1):127–8. [DOI] [PubMed] [Google Scholar]
  • 209. Zhou  Z, Alikhan  NF, Sergeant  MJ, et al.  GrapeTree: visualization of core genomic relationships among 100,000 bacterial pathogens. Genome Res  2018;28(9):1395–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 210. Huson  DH, Bryant  D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol  2006;23:254–67. [DOI] [PubMed] [Google Scholar]
  • 211. Pedersen  NS. https://github.com/johnlees/rapidnj (4 September 2020, date last accessed).
  • 212. Rambaut  A. http://tree.bio.ed.ac.uk/software/figtree (3 September 2020, date last accessed).
  • 213. Yu  G, Smith  DK, Zhu  H, et al.  ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol  2017;8(1):28–36. [Google Scholar]
  • 214. Camacho  C, Coulouris  G, Avagyan  V, et al.  BLAST+: architecture and applications. BMC Bioinformatics  2009;10(1):421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 215. Koboldt  DC. Best practices for variant calling in clinical sequencing. Genome Med  2020;12(1):1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

SupplementaryTable1_elab028
SupplementaryTable2_elab028
SupplementaryTable3_elab028

Articles from Briefings in Functional Genomics are provided here courtesy of Oxford University Press

RESOURCES